PDLIM1 and cardiomyopathy: 4) Furthermore, because PDLIM1/CLP36 has been shown by others to be a biomarker of oxidant/Nrf2 status in cardiomyocytes, and because cardiomyopathy is the cause of death in 80% of Friedreich's cases, a marker of its status could be important for clinical drug development.